Advertisement
News
Advertisement

New Langer startup to develop oral insulin

Mon, 01/10/2011 - 4:38am
Mass High Tech: The Journal of New England Technology

Prolific MIT life sciences inventor Robert Langer is behind a new startup backed by Boston-based drug developer Enlight BioSciences. Entrega Inc. will work to develop oral drug delivery technology for biologic drugs, including insulin and antibodies, which are used to treat diabetes, cancer and inflammatory disease.

Enlight launched in July 2008 out of Boston venture firm PureTech Ventures, where Langer is a founding senior partner. The Boston-based startup has strategic partnerships with drug giants Eli Lilly & Co., Johnson & Johnson, Merck & Co. Inc. and Pfizer Inc., worth $52 million.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading